My research is primarily focused on developing immunohistochemical assays for biomarker development and translational research. The goal is to assist researchers and clinicians with the molecular and morphologic characterization of normal and disease tissues of interest in support of the NYULMC research mission. I have been involved in the field of immunohistochemistry since 1990. In that time, I have amassed a large data set of immunohistochemical markers and protocols, enabling researchers to rapidly asses their targets. More recently, my colleagues and I have begun exploring multiplexing techniques and are currently developing multicolor assays for a variety of applications.
Research Assistant Professor, Department of Pathology
PhD from City College
American journal of surgical pathology. 2018 Aug; 42(8):989-981000
Science translational medicine. 2018 Jun 27; 10(447):
Expression of PRAME is increased in K27M mutant gliomas: Identification of a potential target for immunotherapy [Meeting Abstract]
Journal of neuropathology & experimental neurology. 2018 JUN; 77:489-489
Validation of PD-L1 Immunohistochemical Stain Using Clone 22C3 in Different Automatic Stainer Platforms [Meeting Abstract]
Modern pathology. 2018 MAR; 31:724-724
Molecular therapy oncolytics. 2018 Jan 31; 8:71-81
Seminars in arthritis & rheumatism. 2018 Jan 06;
Cell reports. 2017 Oct 31; 21(5):1267-1280
Membrane Attack Complex (MAC) Deposition in Lupus Nephritis Is Associated with Hypertension and Poor Clinical Response to Treatment [Meeting Abstract]
Arthritis & rheumatology. 2017 OCT; 69:?-?